Font Size: A |  A |  A

VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large Vessel Vasculitis

Study Name: 5515 - VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-Vessel Vasculitis (Takayasu's Arteritis): Development as clinical trial outcome measures

 

Study Status: Recruiting

For:

  • Takayasu's Arteritis (TAK)

    Summary:

    Please Note: The Rare Diseases Clinical Research Network will make every effort to enroll all the patients we can, but we cannot make any guarantees that we will be able to enroll everyone in a particular study who wants to participate.

    Background

    Takayasu's arteritis is a rare disease that affects the blood vessels. Takayasu's arteritis can cause swelling of large and medium-sized blood vessels. The blood vessels that are commonly affected are the branches of the aorta (the main blood vessel that leaves the heart). The purpose of this study is to help doctors learn more about this disease by using x-ray-like tests to see if they are helpful in taking care of patients with Takayasu's arteritis.

    About this Study

    This is an imaging study that compares x-ray-like tests that would not be a part of your regular care (PET/CT) with x-ray-like tests that are a part of your regular care (MRI). At two visits, three months apart, patients will have a PET/CT scan performed at the same time as their MRI scan; some patients with also have a third PET/CT scan. A total of 36 people with Takayasu's arteritis at several hospitals will take part in this study. Doctors will use images from the different time points, along with information from exams and symptoms, to learn more about the disease.

    Target Enrollment:

    To be eligible to participate, you must:

    1. Have a diagnosis of Takayasu's arteritis as defined by the VCRC Longitudinal Study #5503 and be enrolled in the VCRC Longitudinal Study #5503 at the same time.
    2. Be older than 16 years of age. 
    3. Have active disease occurring in combination with a disease relapse within 2 weeks before enrollment.

      Active disease will be defined by the presence of clinical features or imaging or both:

      Clinical features:

      • Constant fever higher than 38o C for longer than 1 week
      • Blood vessel pain/tenderness, scalp tenderness, or an abnormal blood vessels of the head
      • Unusual headaches
      • Limit of blood supply to the eye (retina), damage to the eye nerve, or loss of vision
      • Tongue/jaw pain and/or cramping
      • Brief limit of blood supply in the brain or stroke
      • Pain and/or cramping in body limbs
      • Muscle and bone symptoms (joint swelling or morning stiffness)
      • General feeling of being unwell and tired
      • Other symptoms/signs known by the doctor to be related Takayasu's arteritis
    4. Willing and able to follow the imaging schedule and follow-up procedures
    5. Willing and able to give informed consent

    You are not eligible to participate if:

    1. You are pregnant or breast feeding 
    2. You are not able to follow study rules
    3. You are not able to safely have an MRI scan

    How to Participate:

    In order to participate in a study, you must personally contact the study coordinator of any of the participating institutions by phone or by e-mail. Please use the information below to inquire about participation.

    How to Participate:

    In order to participate in a study, you must personally contact the study coordinator of any of the participating institutions by phone or by e-mail. Please use the information below to inquire about participation.

     
  • Boston University School of Medicine
  • Boston, Massachusetts
    Principal Investigator: Peter Merkel, MD, MPH
    Contact Person: Jessica Martin
    Office: 617-414-2507
    Email: jmartin@bu.edu
     
  • Cleveland Clinic Foundation (VCRC)
  • Cleveland, Ohio
    Principal Investigator: Carol Langford, MD, MHS
    Contact Person: Geetha Krishnan
    Office: 216-445-5930
    Email: Krishng@ccf.org
     

     

    Participation in research studies is voluntary. Deciding not to participate in a research study does not affect your ability to receive care at any of our Clinical Centers or from other physicians.